rs137852896
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_024312.5(GNPTAB):c.310C>T(p.Gln104*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024312.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024312.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | NM_024312.5 | MANE Select | c.310C>T | p.Gln104* | stop_gained | Exon 3 of 21 | NP_077288.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | ENST00000299314.12 | TSL:1 MANE Select | c.310C>T | p.Gln104* | stop_gained | Exon 3 of 21 | ENSP00000299314.7 | ||
| GNPTAB | ENST00000549940.5 | TSL:1 | c.310C>T | p.Gln104* | stop_gained | Exon 3 of 11 | ENSP00000449150.1 | ||
| GNPTAB | ENST00000550352.1 | TSL:3 | n.104C>T | non_coding_transcript_exon | Exon 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151964Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461792Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151964Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74212 show subpopulations
ClinVar
Submissions by phenotype
Mucolipidosis type II Pathogenic:2
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln104*) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with mucolipidosis type II (PMID: 16116615). ClinVar contains an entry for this variant (Variation ID: 2763). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at